Clinical Trial Update: Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy with interferon alfa-2b for unresectable nonmetastatic hepatocellular carcinoma (liver cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Liver Cancer | Phase 2 | Status: UNKNOWN